Omicron BA.2.75 Subvariant of SARS-CoV-2 Is Expected to Have the Greatest Infectivity Compared with the Competing BA.2 and BA.5, Due to Most Negative Gibbs Energy of Binding

被引:18
|
作者
Popovic, Marko [1 ]
机构
[1] Tech Univ Munich, Sch Life Sci, D-85354 Freising Weihenstephan, Germany
来源
BIOTECH | 2022年 / 11卷 / 04期
关键词
BA.2.75; variant; Gibbs energy of binding; binding rate; infectivity; SARS-CoV-2; phenomenological equation; nonequilibrium thermodynamics; chemical kinetics; Omicron; SUPRAMOLECULAR ARCHITECTURE; THERMODYNAMIC THEORY; MICROBIAL-GROWTH; ENTROPY; EVOLUTION;
D O I
10.3390/biotech11040045
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Omicron BA.2.75 may become the next globally dominant strain of COVID-19 in 2022. The BA.2.75 sub-variant has acquired more mutations (9) in spike protein and other genes of SARS-CoV-2 than any other variant. Thus, its chemical composition and thermodynamic properties have changed compared with earlier variants. In this paper, the Gibbs energy of the binding and antigen-receptor binding rate was reported for the BA.2.75 variant. Gibbs energy of the binding of the Omicron BA.2.75 variant is more negative than that of the competing variants BA.2 and BA.5.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] First Detection of the SARS-CoV-2 Omicron BA.5/22B in Monaco
    Colson, Philippe
    Lavagna, Christian
    Delerce, Jeremy
    Groshenry, Guillaume
    Yahi, Nouara
    Fantini, Jacques
    La Scola, Bernard
    Althaus, Thomas
    MICROORGANISMS, 2022, 10 (10)
  • [22] Global challenge with the SARS-CoV-2 omicron BA.2(B.1.1.529.2) subvariant: Should we be concerned?
    Jalil Roohani
    Masoud Keikha
    World Journal of Virology, 2022, (06) : 496 - 501
  • [23] Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are antigenically distinct
    Mykytyn, Anna Z.
    Rissmann, Melanie
    Kok, Adinda
    Rosu, Miruna E.
    Schipper, Debby
    Breugem, Tim, I
    van den Doel, Petra B.
    Chandler, Felicity
    Bestebroer, Theo
    de Wit, Maurice
    van Royen, Martin E.
    Molenkamp, Richard
    Munnink, Bas B. Oude
    de Vries, Rory D.
    GeurtsvanKessel, Corine
    Smith, Derek J.
    Koopmans, Marion P. G.
    Rockx, Barry
    Lamers, Mart M.
    Fouchier, Ron A. M.
    Haagmans, Bart L.
    SCIENCE IMMUNOLOGY, 2022, 7 (75)
  • [24] Variable detection of Omicron-BA.1 and -BA.2 by SARS-CoV-2 rapid antigen tests
    Andreas Osterman
    Irina Badell
    Christopher Dächert
    Nikolas Schneider
    Anna-Yasemin Kaufmann
    Gamze Naz Öztan
    Melanie Huber
    Patricia M. Späth
    Marcel Stern
    Hanna Autenrieth
    Maximilian Muenchhoff
    Alexander Graf
    Stefan Krebs
    Helmut Blum
    Ludwig Czibere
    Jürgen Durner
    Lars Kaderali
    Hanna‑Mari Baldauf
    Oliver T. Keppler
    Medical Microbiology and Immunology, 2023, 212 : 13 - 23
  • [25] Variable detection of Omicron-BA.1 and -BA.2 by SARS-CoV-2 rapid antigen tests
    Osterman, Andreas
    Badell, Irina
    Daechert, Christopher
    Schneider, Nikolas
    Kaufmann, Anna-Yasemin
    Oztan, Gamze Naz
    Huber, Melanie
    Spaeth, Patricia M.
    Stern, Marcel
    Autenrieth, Hanna
    Muenchhoff, Maximilian
    Graf, Alexander
    Krebs, Stefan
    Blum, Helmut
    Czibere, Ludwig
    Durner, Juergen
    Kaderali, Lars
    Baldauf, Hanna-Mari
    Keppler, Oliver T.
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2023, 212 (01) : 13 - 23
  • [26] SARS-CoV-2 Omicron BA.5: Riding the seventh wave in Central Canada
    Li, Anthony
    Yung, Adrian
    Tran, Carolyn
    Boulet, Maximilien
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2022, 16 (06) : 1202 - 1204
  • [27] Introduction, Spread and Impact of the SARS-CoV-2 Omicron Variants BA.1 and BA.2 in Cyprus
    Richter, Jan
    Koptides, Dana
    Tryfonos, Christina
    Alexandrou, Denise
    Christodoulou, Christina
    MICROORGANISMS, 2022, 10 (09)
  • [28] Antibody Titers and Protection against Omicron (BA.1 and BA.2) SARS-CoV-2 Infection
    Dimeglio, Chloe
    Migueres, Marion
    Bouzid, Naemie
    Chapuy-Regaud, Sabine
    Gernigon, Caroline
    Da-Silva, Isabelle
    Porcheron, Marion
    Martin-Blondel, Guillaume
    Herin, Fabrice
    Izopet, Jacques
    VACCINES, 2022, 10 (09)
  • [29] Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission
    Shrestha, Lok Bahadur
    Foster, Charles
    Rawlinson, William
    Tedla, Nicodemus
    Bull, Rowena A.
    REVIEWS IN MEDICAL VIROLOGY, 2022, 32 (05)
  • [30] Structurally defined heparin octasaccharide domain for binding to SARS-CoV-2 Omicron BA.4/BA.5/BA.5.2 spike protein RBD
    An, Zizhe
    Bu, Changkai
    Shi, Deling
    Chen, Qingqing
    Zhang, Bin
    Wang, Qingchi
    Jin, Lan
    Chi, Lianli
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 259